RankAlpha logo
Back to Rankings

SOPH

SOPHiA GENETICSC
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-21
View Chart
Current thesis
The post-earnings bull read is that Q1 showed real commercial traction: 22% revenue growth, 117% net dollar retention, record platform usage, 28% U.S. analysis-volume growth, and maintained 20%-22% full-year revenue guidance all support the argument that 2025 signings are starting to convert [#6K-2026-05-05].
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +10.2.
What can break
FX and international operating exposure can pressure reported results even if underlying demand stays healthy, a risk management discussed on the earnings call transcript.
Momentum
71
Value
37
Sentiment
55
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $6.80 · Bull $8.50 · Bear $4.20
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-08 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $9.00
Why
Momentum71 · Δ7d +10.2
Value37 · Δ7d 0.0
Sentiment55 · Δ7d -14.6
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
71
26% active weight
Current posture
7d trendImproving
Δ7d
+10.2
Δ21d
-
Value
37
39% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.2
Sentiment
55
34% active weight
Current posture
7d trendSoftening
Δ7d
-14.6
Δ21d
-
Why this grade

Composite grade C. Momentum 71.4 / Value 36.5 / Sentiment 55.0

Fundamentals (TTM)
As of 2026-07-21
Market Cap
$545.32M
Beta
1.11
Shares Out
83.9M
P/E (TTM) · Derived
-5.6
P/S (TTM)
4.26
P/FCF (TTM) · Derived
-9.69
Rev YoY
+22.0%
EPS YoY
+4.4%
Gross Margin
+67.3%
Op Margin
-95.3%
Net Debt
-$7.27M
Current Ratio
2.06
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology